Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Neutropenia Therapy
Findings from Maudsley Hospital advance knowledge in neutropenia therapy
April 16th, 2007
Investigators publish new data in the report "Restarting clozapine after neutropenia: evaluating the possibilities and practicalities." According to a study from London, the United Kingdom, "Clozapine remains the antipsychotic of choice for refractory schizophrenia despite its propensity for serious blood disorders. When neutropenia or agranulocytosis occur in people taking clozapine, cessation of treatment is mandated and relapse often results." "Because such patients are usually unresponsive to other antipsychotics, many clinicians consider restarting clozapine, despite the risks involved. However, the risks of clozapine rechallenge vary according to the cause and...
Source: Hematology Week (2007-04-16)
|
